Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.
The Race for the Next Ozempic - WIRED
Jul 24, 2024 · Their success has sparked a frenzy among pharmaceutical companies looking for the next blockbuster weight-loss drug. Researchers are now racing to develop new anti-obesity medications that...
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in...
FDA Approves Most Potent Weight Loss Drug Yet | TIME
Nov 9, 2023 · The FDA’s approval of tirzepatide, following the approval of semaglutide in 2021, gives doctors and patients two of the most potent drugs yet to treat weight loss.
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
Nov 8, 2023 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs.
F.D.A. Approves New Obesity Drug That Will Compete With Wegovy
Nov 8, 2023 · New Obesity Drug MariTide: The pharmaceutical manufacturer Amgen announced that MariTide, an experimental obesity drug given once a month, helped patients lose up to 20 percent of their weight in...
New Weight Loss Drugs That Became Popular in 2022: Risks, …
Nov 25, 2022 · Medications like semaglutide and tirzeptide are part of a new era of weight loss drugs, helping to curb cravings for junk food and even alcohol.
16 New Weight Loss Drugs - GoodRx
Oct 1, 2024 · Several new weight-loss drugs are making waves in clinical trials. This includes pills such as oral semaglutide, orforglipron, and amycretin. The same goes for injectable medications, such as retatrutide, CagriSema (cagrilintide and semaglutide), and …
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
Nov 9, 2023 · A new weight loss drug has been approved that promises to be the most effective medication yet. Zepbound belongs to a new class of medications, alongside Ozempic and Wegovy, that have...